Association of Hyperlipidemia on the Prevalence and Risk Factors of Kidney Stones and Hypertension
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background This study aimed to assess the risk of kidney stones in a hyperlipidemic population and explore the development risk and related indicators with or without hypertension. Methods A cross‐sectional study included 1000 hyperlipidemic patients from Nanshan District Medical Group Headquarters, Shenzhen, 2021. Measurements covered BMI, blood pressure, renal function, and urinalysis. Descriptive statistics, group comparisons, and a logistic regression model were used, with p < 0.05 for significance. Results Among 1000 hyperlipidemic patients, 23.3% had hypertension, and the kidney stone prevalence was 15.4%. Double kidney stones were more common in the hypertensive group (40.6%). Logistic regression showed that males, elevated blood urea nitrogen, and positive glycosylated hemoglobin were independent risk factors for kidney stones. In the hypertension–hyperlipidemia subgroup, a higher stone prevalence was noted in those patients aged 60–69 years (OR = 2.92, 95% CI: 1.04–8.20, p = 0.014) and elevated blood creatinine (OR = 4.47, 95% CI: 1.36–14.65, p = 0.040). After adjustment, elevated blood creatinine remained an independent risk factor. Conclusions The kidney stone prevalence in hyperlipidemic patients was 15.4%. Age, gender, blood creatinine, urea nitrogen, and glycosylated hemoglobin are key factors for kidney stone development.
Fields of Study & Subjects
Kidney Stones and Urolithiasis Treatments
Gout
Hyperuricemia
Uric Acid
Chronic Kidney Disease and Diabetes
Publication details
- Journal / source
- Advances in Urology
- Volume
- 2026
- Issue
- 1
- Pages
- 5475508
- Publication date
- 1 January 2026
- Language
- EN